18.02.2013 - U.S. Food and Drug Administration Priority Review Designation for HIV Integrase Inhibitor "Dolutegravir"
18 Feb 2013
18.02.2013 U.S. Food and Drug Administration Priority Review Designation for HIV Integrase Inhibitor "Dolutegravir"
© Shionogi B.V. 2020. All rights reserved. This website is owned by Shionogi B.V. Registered with the Trade Register of the Dutch Chamber of Commerce under number 73229180. Registered address is Kingsfordweg 151, 1043GR, Amsterdam, the Netherlands.
Report Side Effect
Just to let you know, you are now moving to another website this is not under our control and Shionogi Limited is not responsible for its contents.